Wydawca
|
|
ukazuje się od 1994 roku |
| Wydawca
|
|
ukazuje się od 1994 roku |
» Leczenie zakażeń dróg oddechowych© Borgis - Nowa Medycyna 1, s. 8-12
*Janusz Milanowski, Katarzyna Szmygin-Milanowska
Leczenie zakażeń dróg oddechowych
TREATMENT OF RESPIRATORY TRACT INFECTIONS
Klinika Pneumonologii, Onkologii i Alergologii, Samodzielny Publiczny Szpital Kliniczny nr 4 w Lublinie
Kierownik Kliniki: prof. dr hab. Janusz Milanowski Summary
Key words:
Piśmiennictwo
1. The AGREE Collaboration Writing Group: Development and validation of an international appraisal instruments for assessing the quality of clinical practice guidelines: The AGREE Project. Quality Safety Health Care 2003; 12: 18-23. 2. Szmygin-Milanowska K, Buczkowski J: Leczenie zakażeń dróg oddechowych w świetle najnowszych rekomendacji- spojrzenie lekarza praktyka. îwiat Medycyny 2006; 72: 14-25. 3. Falco V et al.: Influence of penicillin resistance on outcome in adult patient with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains. J Antimicrob Chemother 2004; 54: 481-8. 4. Martinez J et al.: Addition of a macrolide to a betalactam based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2003; 36: 389-95. 5. Fogarty C et al.: Multicenter, open label randomised study to compare the safety and efficacy of levofloxacin versus ceftriaxone sodium and erythromycin followed by clarithromycin and amoxicillin-clavulante in the treatment of serious community acquired pneumonia in adults. Clin Infect Dis 2004; 38: 16-23. 6. Leroy O et al.: Comparison of levofloxacin and cefotaxim combined with ofloxacin for ICU Patients with Community Acquired Pneumonia who do not required vasopressors. Chest 2005; 128: 172-83. 7. File T: Clinical efficacy of Newer Agents in Short Duration Therapy of Community Acquired Pneumonia. Clin Infect Dis 2004; 39: 159-64. 8. Castro-Guardiola A et al.: Efficacy and Safety of Oral and Early switch Therapy for Community-acquired Pneumonia: A Randomized Controlled Trial. Am J Med 2001; 111: 367-74. 9. Fine M et al.: Implementation of an Evidence Based Guideline to Reduce Duration of Intravenous Antibiotic Therapy and Length of Stay for Patients Hospitalized with Community-Acquired Pneumonia: A Randomized Controlled Trial. Am J Med 2003; 115: 343-51. 10. Israel H et al.: Delayed resolution of pneumonias. Med Clin North Am 1956; 40: 1291-303. 11. Metlay J, Kapoor W, Fine M: Does this patient have community acquired pneumonia? Diagnosing pneumonia by history and physical examination. JAMA 1997; 278: 1440-5. 12. Diehr P et al.: Prediction of pneumonia in outpatients with acute cough - a statistical approach. J Chronic Dis 1984; 37: 215-25. 13. Korppi M et al.: Rhinovirus - associated wheezing in infancy: a comparison with respiratory syncytial virus bronchiolitis. Ped Infec Dis J 2004; 23: 995-9. 14. Ramirez J, Bordon J: Early Switch From Intarvenous to Oral Antibiotics in Hospitalized Patients With Bacteremic Community Acquired Streptococcus pneumoniae Pneumonia. Arch Intern Med 2001; 161: 848-50. 15. Leroy O et al.: Comparison of levofloxacin and cefotaxim combined with ofloxacin for ICU Patients with Community Acquired Pneumonia who do not required vasopressors. Chest 2005; 128: 172-83. 16. Lim W et al.: Study of community acquired pneumonia etiology in adults admitted to hospital: implications for management guidelines. Thorax 2001; 56: 296-301. 17. Lindbaek M, Hjortdahl P, Johnsesn U: Use of symptoms, signs, and blood tests to diagnose acute sinus infections in primary care. Fam Med 1996; 28: 183-8. 18. Linder J, Randall S: Antibiotic Treatment of Adults with Sore Throat by Community Primary Care Physicans. JAMA 2001; 286: 1181-6. 19. Macfarlane J et al.: Prospective study of the incidence, etiology and outcome of adult lower respiratory tract illness in the community. Thorax 2001; 56: 109-14. 20. Garofalo R et al.: A comparison of epidemiologic and immunologic features of bronchiolitis caused by influenza virus and respiratory syncytial virus. J Med Virol 2005; 75: 282-9. 21. Korppi M., Kotaniemi-Syrjanen A., Waris M. i wsp.: Rhinovirus - associated wheezing in infancy: a comparison with respiratory syncytial virus bronchiolitis. Ped Infec Dis J 2004; 23: 995-9. 22. Foulongne V et al.: Human metapneumovirus infection in young children hospitalised with respiratory tract disease. Ped Infec Dis J 2006; 25: 354-9.
otrzymano/received: 2009-02-25 zaakceptowano/accepted: 2009-03-27 Adres/address: *Janusz Milanowski Katedra i Klinika Pneumonologii, Onkologii i Alergologii ul. Jaczewskiego 8, 20-093 Lublin tel.: (0-81) 724-44-31 e-mail: janusz.milanowski@am.lublin.pl Pełna wersja artykułu Leczenie zakażeń dróg oddechowych dostępna w Czytelni Medycznej Borgis. |
english version
